In terms of tumor weight on the 14th day, 6 and 12 mg/kg CAT3 (a prodrug of PF403) also achieved 55.37% and 63.18% inhibitory effects, respectively (Fig. 6D). Here, SLC7A3 is linked to neoplasm.